Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|August 9, 2016
Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphomaJeff Hosry, Parag Mahale, Francesco Turturro, et al.
European Journal of Gastroenterology & Hepatology|September 5, 2022
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virusMarcel Yibirin, Jeff Hosry, Eduardo Yepez Guevara, et al.
Diagnostic Microbiology and Infectious Disease|June 15, 2017
False-positive HIV nucleic acid amplification testing during CAR T-cell therapyElla J Ariza-Heredia, Bruno P Granwehr, George M Viola, et al.
The Lancet. Infectious Diseases|September 1, 2004
West Nile virus: where are we now?Bruno P Granwehr, Kristy M Lillibridge, Stephen Higgs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2024
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer CenterHarrys A Torres, Khalis Mustafayev, Ruston P Juneau, et al.
Journal of Oncology Practice|August 6, 2015
HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer CenterJessica P Hwang, Bruno P Granwehr, Harrys A Torres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disordersTom Solomon, Ann F Fisher, David W C Beasley, et al.
The Pediatric Infectious Disease Journal|January 10, 2012
Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancerDimpy P Shah, Katia K El Taoum, Jharna N Shah, et al.
The American Journal of Gastroenterology|November 10, 2018
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational StudyHarrys A Torres, Minas P Economides, Georgios Angelidakis, et al.
The American Journal of Gastroenterology|June 12, 2023
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid TumorsMarcel Yibirin, Khalis Mustafayev, Jeff Hosry, et al.
Pageof 3